The $800 million pill : the truth behind the cost of new drugs /

"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescrip...

Full description

Saved in:
Bibliographic Details
Online Access: Contributor biographical information
Table of contents
Publisher description
Main Author: Goozner, Merrill, 1950-
Format: Book
Language:English
Published: Berkeley : University of California Press, 2004
Subjects:

MARC

LEADER 00000cam a22000004a 4500
001 p765831
005 20231013105342.0
008 031010t20042004cau b 001 0 eng
010 |a  2003063422 
015 |a GBA4-Z1147 
016 7 |a 101213652  |2 DNLM 
020 |a 0520239458 (hbk. : alk. paper) 
035 |a (OCoLC)53223691 
040 |a DLC  |c DLC  |d MNY  |d NLM  |d UKM  |d UtOrBLW 
042 |a pcc 
049 |a MPAA 
050 0 0 |a RS100  |b .G668 2004 
082 0 0 |a 338.4/3/61510973  |2 22 
100 1 |a Goozner, Merrill,  |d 1950-  |0 n 2003016040 
245 1 5 |a The $800 million pill :  |b the truth behind the cost of new drugs /  |c Merrill Goozner. 
246 3 |a Eight hundred million dollar pill 
264 1 |a Berkeley :  |b University of California Press,  |c [2004] 
264 4 |c ©2004 
300 |a 297 pages ;  |c 24 cm 
336 |a text  |b txt  |2 rdacontent 
337 |a unmediated  |b n  |2 rdamedia 
338 |a volume  |b nc  |2 rdacarrier 
504 |a Includes bibliographical references (p. 281-283) and index. 
520 |a "Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescription drugs. Goozner demonstrates that almost all of the important and life-saving new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and the National Institutes of Health ... [Goozner] suggests ways that the government's role in testing new medicines could be expanded to eliminate private-sector waste driving up the cost of existing drugs--p. [2] of jacket. 
650 0 |a Prescription pricing.  |0 sh 85106437  
650 0 |a Drugs  |x Prices.  |0 sh 91005431  
650 0 |a Pharmaceutical industry.  |0 sh 85039713  
650 0 |a Consumer education.  |0 sh 85031483  
650 7 |a Medication.  |2 homoit  |0 homoit0001007 
650 7 |a Therapies.  |2 homoit  |0 homoit0001366 
856 4 2 |3 Contributor biographical information  |u http://www.loc.gov/catdir/bios/ucal052/2003063422.html  |t 0 
856 4 1 |3 Table of contents  |u http://www.loc.gov/catdir/toc/ucal041/2003063422.html  |t 0 
856 4 2 |3 Publisher description  |u http://www.loc.gov/catdir/description/ucal042/2003063422.html  |t 0 
951 |a 765831 
994 |a X0  |b MPA 
999 f f |i 7e0b1881-8f55-5b4b-87a9-bf5a7789d297  |s 070eab30-8814-5d09-943e-30bf9e0db9e9  |t 0 
952 f f |p Can circulate  |a Massachusetts College of Pharmacy and Health Sciences  |b Boston Campus  |c MCPHS Boston Library  |d Boston Circulation  |t 0  |e RS100 .G668 2004  |h Library of Congress classification  |i Book  |m 0113401664595